Ohio Student Suspended for Making Replica Battlefield

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
153
Ohio Student Suspended for Making Replica
Battlefield Cross for History Project < >



An Ohio middle-school student spoke out Thursday on "Fox & Friends" after he was suspended from school for making a battlefield cross replica as part of a history project.

Celina Middle School eighth-grade student Tyler Carlin said he told his teacher that he was going to replicate the iconic military symbol and the teacher said it would be OK.

Since he used a toy Nerf dart gun to make the project, administrators objected to it being in the school, saying it violated their policies.

Carlin said when he arrived at school with the cross on March 5, it was taken away from him and he was later given a three-day in-school suspension.

The school declined to elaborate on the decision in a statement to "Fox & Friends." Not everyone at the school was supportive of the discipline, however.

"I just sat in a room all day. An administrator thought it was stupid that I got this, so she brought me a doughnut and played cards with me," he said, adding that many residents are protesting the decision.

Carlin's attorney, Travis Faber, said he wants the school district to expunge the "ridiculous" suspension from Carlin's record. He also criticized the school board for not allowing an Army staff sergeant to speak on the matter at a recent school board meeting.

"This is an administration that frankly, just wasn't using common sense," said Faber.

Faber said he asked the school to delay the suspension before it went into effect, but the school refused.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lumexa Imaging's Investor Conference Push: Any Real Substance?

Updated Category News Views 132

Lumexa Imaging just dropped a line on Feb 17, 2026, about their upcoming investor conference gigs. Sure, they're strutting into multiple events—Raymond James in Orlando, Leerink Partners in Miami, and Barclays back-to-back days after that. But here’s the kicker: are these talks really worth the buzz? In a space where outpatient imaging claims to be kingpin, you’ve...

Continue Reading
Current Landscape of US Stock Futures Amid Rate Cuts

Updated Category News Views 173

Insights on the Current Stability of U.S. Stock Futures During Asian trading hours, U.S. stock index futures have held steady. Investors are hoping for interest rate cuts as the Federal Reserve's next meeting approaches. This meeting is expected to reveal a significant easing cycle that many in the market are eagerly anticipating. Even with strong reports on consumer and...

Continue Reading
Wispr Flow Revolutionizes Voice Dictation Across Platforms

Updated Category News Views 469

Wispr Flow Expands Its Reach in Voice Dictation Technology In a world where speed and efficiency are paramount, Wispr, known as The Voice Interface Company, is revolutionizing the way we interact with technology. With the recent launch of Wispr Flow for Windows, this innovative voice productivity tool is now accessible to users across both Mac and Windows platforms,...

Continue Reading
MintMiner: Your Ultimate Gateway to Cloud Mining Success

Updated Category News Views 197

Unlocking the Future of Cloud Mining with MintMiner In today's uncertain financial landscape, MintMiner presents an innovative solution for anyone looking to tap into the world of digital assets. As global financial systems face challenges, MintMiner offers a unique platform that makes cloud mining accessible, straightforward, and profitable. Understanding Cloud Mining...

Continue Reading
GT Biopharma's Strategic Move: Withdrawal of S-1 Registration

Updated Category News Views 100

GT Biopharma's Strategic Withdrawal of Form S-1 Registration GT Biopharma, Inc. (NASDAQ: GTBP) recently made headlines with its request for withdrawal of a Form S-1 registration statement. This decision marks a crucial moment for the company, based in San Francisco, known for its innovative approach in the immuno-oncology sector. GT Biopharma focuses on the development of...

Continue Reading